Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PRF TechnologiesPRFX -2.38%22 Days Payable is 643.64 as of Jun. 2026, which is 51% below its 10-year median of 1,327.04. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 925 Drug Manufacturers companies, PRF Technologies ranks better than 94.59% on this metric.
The historical rank and industry rank for PRF Technologies's Days Payable or its related term are showing as below:
PRFX'
s Days Payable Range Over the Past 10 Years
Min: 539.78 Med: 1327.04 Max: 1327.04
Current: 539.78
During the past 8 years, PRF Technologies's highest Days Payable was 1327.04. The lowest was 539.78. And the median was 1327.04.
PRFX's Days Payable is ranked better than 94.59% of 925
companies
in the Drug Manufacturers industry
Industry Median: 88.64
vs PRFX: 539.78
PRF Technologies's Days Payable
increased
from Jun. 2025 (0.00) to Jun. 2026 (643.64).
It may suggest that PRF Technologiesdelayed paying its suppliers.
The historical data trend for PRF Technologies's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRF Technologies Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where PRF Technologies's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PRF Technologies's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRF Technologies (PRFX) has a Days Payable of 643.64 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PRF Technologies and its competitors. This is 51% below median its historical median of 1,327.04. Over the past decade, PRF Technologies' Days Payable has ranged from 539.78 to 1,327.04. According to the industry distribution chart, PRF Technologies ranks #50 out of 925 companies in the Drug Manufacturers industry, placing it in the top 5.4%.
Is PRF Technologies' Days Payable too high?
PRF Technologies' current Days Payable of 643.64 is 51% below median its 10-year median of 1,327.04. Over the past 10 years, this metric has ranged from a low of 539.78 to a high of 1,327.04. The Drug Manufacturers industry median Days Payable is 88.64. PRF Technologies' value of 643.64 is 626.1% above this industry median. Based on the distribution chart, PRF Technologies ranks #50 out of 925 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' Days Payable compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #50 out of 925 companies for Days Payable. This places PRF Technologies in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 88.64. PRF Technologies' value of 643.64 is 626.1% above this benchmark. Historically, PRF Technologies' own Days Payable has ranged from 539.78 to 1,327.04 over the past decade. While the company's 10-year median is 1,327.04 vs. the industry median of 88.64, PRF Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.64, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PRF Technologies's current Days Payable of 643.64 is 626.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PRF Technologies and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PRF Technologies's current Days Payable is 643.64, which is 51% below median its own 10-year median of 1,327.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current Days Payable of 643.64. The current Days Payable is 643.64, which is 51% below median its 10-year median of 1,327.04 and 626.1% above the Drug Manufacturers industry median of 88.64. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PRF Technologies (PRFX), the current Days Payable is 643.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score
Get the complete analysis for PRFX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRFX has been successfully added to your 
